Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

NEWS PROVIDED BY

Cohen & Steers, Inc.

Aug 28, 2026, 17:47 ET

SHARE THIS ARTICLE

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on August 31, 2026 and cumulative distributions paid fiscal year-to-date.

In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund's shares. 

The Fund's monthly distributions may include long-term capital gains, short-term capital gains, net investment income and/or return of capital for federal income tax purposes. Return of capital includes distributions paid by the Fund in excess of its net investment income and net realized capital gains and such excess is distributed from the Fund's assets. A return of capital is not taxable; rather, it reduces a shareholder's tax basis in his or her shares of the Fund. The amount of monthly distributions may vary depending on a number of factors, including changes in portfolio and market conditions.

At the time of each monthly distribution, information will be posted to cohenandsteers.com and mailed to shareholders in a concurrent notice. However, this information may change at the end of the year because the final tax characteristics of the Fund's distributions cannot be determined with certainty until after the end of the calendar year. Final tax characteristics of all of the Fund's distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year.

The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year-to-date from the sources indicated. All amounts are expressed per common share.

DISTRIBUTION ESTIMATES

August 2026

YEAR-TO-DATE (YTD)

August 31, 2026*

Source

Per Share

Amount

% of Current

Distribution

Per Share

Amount

% of 2026

Distributions

Net Investment Income

$0.0342

39.31 %

$0.2481

35.65 %

Net Realized Short-Term Capital Gains

$0.0000

0.00 %

$0.0000

0.00 %

Net Realized Long-Term Capital Gains

$0.0528

60.69 %

$0.4479

64.35 %

Return of Capital (or other Capital Source)

$0.0000

0.00 %

$0.0000

0.00 %

Total Current Distribution

$0.0870

100.00 %

$0.6960

100.00 %

You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution policy.  The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of distributions year-to-date may be subject to additional adjustments.

*THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES.

The Fund's Year-to-date Cumulative Total Return for fiscal year 2026 (January 1, 2026 through July 31, 2026) is set forth below. Shareholders should take note of the relationship between the Year-to-date Cumulative Total Return with the Fund's Cumulative Distribution Rate for 2026. In addition, the Fund's Average Annual Total Return for the five-year period ending July 31, 2026 is set forth below. Shareholders should note the relationship between the Average Annual Total Return with the Fund's Current Annualized Distribution Rate for 2026. The performance and distribution rate information disclosed in the table is based on the Fund's net asset value per share (NAV). The Fund's NAV is calculated as the total market value of all the securities and other assets held by the Fund minus the total liabilities, divided by the total number of shares outstanding. While NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's individual investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. 

Fund Performance and Distribution Rate Information:

Year-to-date January 1, 2026 to July 31, 2026                                                                 

Year-to-date Cumulative Total Return1

6.68 %

Cumulative Distribution Rate2

5.17 %

Five-year period ending July 31, 2026

Average Annual Total Return3

8.08 %

Current Annualized Distribution Rate4

7.75 %

1.

Year-to-date Cumulative Total Return is the percentage change in the Fund's NAV over the year-to-date time period including distributions paid and assuming reinvestment of those distributions.

2.

Cumulative Distribution Rate for the Fund's current fiscal period (January 1, 2026 through August 31, 2026) measured on the dollar value of distributions in the year-to-date period as a percentage of the Fund's NAV as of July 31, 2026.

3.

Average Annual Total Return represents the compound average of the Annual NAV Total Returns of the Fund for the five-year period ending July 31, 2026. Annual NAV Total Return is the percentage change in the Fund's NAV over a year including distributions paid and assuming reinvestment of those distributions.

4.

The Current Annualized Distribution Rate is the current fiscal period's distribution rate annualized as a percentage of the Fund's NAV as of July 31, 2026.

Investors should consider the investment objectives, risks, charges and expense of the Fund carefully before investing. You can obtain the Fund's most recent periodic reports, when available, and other regulatory filings by contacting your financial advisor or visiting cohenandsteers.com. These reports and other filings can be found on the Securities and Exchange Commission's EDGAR Database. You should read these reports and other filings carefully before investing.

Shareholders should not use the information provided here in preparing their tax returns. Shareholders will receive a Form 1099-DIV for the calendar year indicating how to report Fund distributions for federal income tax purposes.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.  

Forward-Looking Statements

This press release and other statements that Cohen & Steers may make may contain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which reflect the company's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates," or the negative versions of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties.

Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

Website: https://www.cohenandsteers.com 

Symbol: (NYSE: CNS)

SOURCE Cohen & Steers, Inc.

21%

more press release views with 

Request a Demo

Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

NEWS PROVIDED BY

Cohen & Steers, Inc.

Aug 28, 2026, 17:51 ET

SHARE THIS ARTICLE

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on August 31, 2026 and cumulative distributions paid fiscal year-to-date.

In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund's shares. 

The Fund's monthly distributions may include long-term capital gains, short-term capital gains, net investment income and/or return of capital for federal income tax purposes. Return of capital includes distributions paid by the Fund in excess of its net investment income and net realized capital gains and such excess is distributed from the Fund's assets. A return of capital is not taxable; rather, it reduces a shareholder's tax basis in his or her shares of the Fund. In addition, distributions from the Fund's investments in MLPs are attributed to various sources, including net investment income and return of capital. The amount of monthly distributions may vary depending on a number of factors, including changes in portfolio and market conditions.

At the time of each monthly distribution, information will be posted to cohenandsteers.com and mailed to shareholders in a concurrent notice. However, this information may change at the end of the year because the final tax characteristics of the Fund's distributions cannot be determined with certainty until after the end of the calendar year. Final tax characteristics of all of the Fund's distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year.

The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year-to-date from the sources indicated. All amounts are expressed per common share.

DISTRIBUTION ESTIMATES

August 2026

YEAR-TO-DATE (YTD)

August 31, 2026*

Source

Per Share

Amount

% of Current

Distribution

Per Share

Amount

% of 2026

Distributions

Net Investment Income

$0.0000

0.00 %

$0.5641

43.73 %

Net Realized Short-Term Capital Gains

$0.0000

0.00 %

$0.0000

0.00 %

Net Realized Long-Term Capital Gains

$0.1650

100.00 %

$0.7259

56.27 %

Return of Capital (or other Capital Source)

$0.0000

0.00 %

$0.0000

0.00 %

Total Current Distribution

$0.1650

100.00 %

$1.2900

100.00 %

You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution policy.  The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of distributions year-to-date may be subject to additional adjustments.

*THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES.

The Fund's Year-to-date Cumulative Total Return for fiscal year 2026 (January 1, 2026 through July 31, 2026) is set forth below. Shareholders should take note of the relationship between the Year-to-date Cumulative Total Return with the Fund's Cumulative Distribution Rate for 2026. In addition, the Fund's Average Annual Total Return for the five-year period ending July 31, 2026 is set forth below. Shareholders should note the relationship between the Average Annual Total Return with the Fund's Current Annualized Distribution Rate for 2026. The performance and distribution rate information disclosed in the table is based on the Fund's net asset value per share (NAV). The Fund's NAV is calculated as the total market value of all the securities and other assets held by the Fund minus the total liabilities, divided by the total number of shares outstanding. While NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's individual investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. 

Fund Performance and Distribution Rate Information:

Year-to-date January 1, 2026 to July 31, 2026                                                                      

Year-to-date Cumulative Total Return1

14.68 %

Cumulative Distribution Rate2

4.58 %

Five-year period ending July 31, 2026

Average Annual Total Return3

8.87 %

Current Annualized Distribution Rate4

7.03 %

1.

Year-to-date Cumulative Total Return is the percentage change in the Fund's NAV over the year-to-date time period including distributions paid and assuming reinvestment of those distributions.

2.

Cumulative Distribution Rate for the Fund's current fiscal period (January 1, 2026 through August 31, 2026) measured on the dollar value of distributions in the year-to-date period as a percentage of the Fund's NAV as of July 31, 2026.

3.

Average Annual Total Return represents the compound average of the Annual NAV Total Returns of the Fund for the five-year period ending July 31, 2026. Annual NAV Total Return is the percentage change in the Fund's NAV over a year including distributions paid and assuming reinvestment of those distributions.

4.

The Current Annualized Distribution Rate is the current fiscal period's distribution rate annualized as a percentage of the Fund's NAV as of July 31, 2026.

Investors should consider the investment objectives, risks, charges and expense of the Fund carefully before investing. You can obtain the Fund's most recent periodic reports, when available, and other regulatory filings by contacting your financial advisor or visiting cohenandsteers.com. These reports and other filings can be found on the Securities and Exchange Commission's EDGAR Database. You should read these reports and other filings carefully before investing.

Shareholders should not use the information provided here in preparing their tax returns. Shareholders will receive a Form 1099-DIV for the calendar year indicating how to report Fund distributions for federal income tax purposes.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.  

Forward-Looking Statements

This press release and other statements that Cohen & Steers may make may contain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which reflect the company's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates," or the negative versions of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties.

Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

Website: https://www.cohenandsteers.com 

Symbol: (NYSE: CNS)

SOURCE Cohen & Steers, Inc.

21%

more press release views with 

Request a Demo

PLAB Deadline: PLAB Investors with Losses in Excess of $100K Have Opportunity to Lead Photronics, Inc. Securities Fraud Lawsuit

NEWS PROVIDED BY

THE ROSEN LAW FIRM, P. A.

Aug 28, 2026, 17:52 ET

SHARE THIS ARTICLE

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Photronics, Inc. (NASDAQ: PLAB) between December 10, 2025 and May 27, 2026, inclusive (the "Class Period"), of the important September 4, 2026 lead plaintiff deadline.

So what: If you purchased Photronics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Photronics class action, go to https://rosenlegal.com/cases/photronics-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 4, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Photronics' high-end product pipeline, customer schedules, and the stability of the alleged demand for its products; notably, that the seasonal recovery and design release momentum following the Chinese New Year holiday, which Photronics was claiming would develop, had stalled. Photronics was experiencing a critical bottleneck in its design release pipeline that rendered its forward growth expectations unachievable. When the true details entered the market, the lawsuit claims that investors suffered damages. 

To join the Photronics class action, go to https://rosenlegal.com/cases/photronics-inc/join   or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     case@rosenlegal.com

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

21%

more press release views with 

Request a Demo

28.08.2026 – 17:45

nd.DerTag / nd.DieWoche

Kommentar von "nd.DerTag" zur Lage im Iran-Krieg

Berlin (ots)

enau sechs Monate liegen der Iran auf der einen Seite sowie die USA und Israel auf der anderen miteinander im Krieg, ausgelöst durch einen völkerrechtlichen Angriff ohne Kriegserklärung auf die Islamische Republik. Für die USA ist das fast normal: Regierungen in Washington sind geübt darin, ein Land als gefährlich für die eigenen Interessen darzustellen, um es dann mit Bomben zu überziehen. Venezuela oder der Irak sind dafür bekannte Beispiele.

Wie der Iran-Krieg weitergehen wird, ist indes völlig unklar. Die US-Regierung hat offensichtlich keine Strategie und auch kein klares Kriegsziel. Die Straße von Hormus bleibt für den Schiffsverkehr blockiert und der Iran ist gewillt, nicht klein beizugeben. Doch die Islamische Republik als Sieger im Krieg zu bezeichnen, wie es Beobachter und Analysten seit Wochen tun, ist eine recht verquere Auffassung darüber, wie man als Sieger aus einem militärischen Konflikt hervorgeht. Über 4000 Menschen sind durch die Bombardements der USA und Israels ums Leben gekommen, die Infrastruktur wurde erheblich in Mitleidenschaft gezogen. Die Kriegsschäden sollen die 200-Milliarden-Dollar-Marke weit überschritten haben. Israelische und US-amerikanische Opfer des Krieges summieren sich dabei auf nicht mal einhundert Menschen - wohlgemerkt jeder einer zu viel.

Nur weil der Iran die Meerenge von Hormus zu kontrollieren in der Lage ist und so weltweit die Kosten für Erdöl und Dünger steigen lässt, ist das Land sicher kein Gewinner - auch wenn es sich selbst gerne so präsentiert. Es klingt mindestens zynisch, dem Iran einen Sieg anzudichten, nur weil man in West und Ost mehr bezahlen muss fürs Benzin an der Tankstelle. Man wird den Eindruck nicht los, dass die Experten schlicht enttäuscht sind über den Status quo, der nicht das ist, was sich viele versprochen hatten: den Sturz des iranischen Regimes.

Nach dieser Logik ist es mit dem im internationalen Recht als vielleicht höchstes Prinzip verankerten Gewaltverbots nicht weit her. Das Zusammenbrechen der Islamischen Republik unter den Bomben der USA und Israels hätte im politischen Diskurs rückwirkend als Legitimation für diesen und auch zukünftige Kriege gedient und all jene in der Auffassung bestätigt, dass eine interventionistische Außenpolitik, wenn sie denn ein sogenanntes Unrechtsregime wegfegt, gerechtfertigt sei, ja den Rechtsbruch sogar heilt. Das tut sie nicht. Es ist einfacher, hier von Imperialismus zu sprechen.

Gewinner sind sicher die Mineralölkonzerne und die Waffenproduzenten. Die USA werden ihre Waffendepots mit Großaufträgen auffüllen müssen; auch in die Taschen von Shell, Aral und Total fließt mehr Geld. Der "normale" Iraner und die "normale" Iranerin haben keinerlei Vorteile aus dem Krieg ziehen können. Die innerstaatliche Repression läuft weiter, ein Sturz der Islamischen Republik scheint zum derzeitigen Zeitpunkt ausgeschlossen und die Beziehungen zu den Nachbarstaaten sind an einem Tiefpunkt angelangt. Und während das US-Militär die Bomben über Teheran, Isfahan oder Bandar Abbas abwarf, ließ das iranische Regime über 500 Menschen hinrichten.

Pressekontakt:

nd.DerTag / nd.DieWoche

Redaktion

Telefon: 030/2978-1722

Original-Content von: nd.DerTag / nd.DieWoche, übermittelt durch news aktuell

28.08.2026 – 17:46

Frankfurter Rundschau

Rot-grüner Aufschwung

Frankfurt (ots)

Es gibt bemerkenswerte Bewegung vor der Landtagswahl in Sachsen-Anhalt. Die SPD, die noch vor Wochen befürchten musste, an der Fünf-Prozent-Hürde zu scheitern, legt mit jeder Umfrage zu. Die Grünen, die seit zweieinhalb Jahren in Umfragen abgeschlagen schienen, stabilisieren sich ebenfalls über fünf Prozent. Ob es die überparteiliche Initiative "Taktisch wählen" war, die die demokratische Wählerschaft aufgeschreckt hat, kann niemand sagen. Frustrierend sind die jüngsten Umfragen hingegen für das BSW. Die Sahra-Wagenknecht-Partei befindet sich auf dem Weg bergab. Offensichtlich hat ihre jüngste Kehrtvolte den Eindruck hinterlassen, dass sie im Zweifel auch eine Regierung von Gnaden der AfD in den Sattel heben würde. Das kommt beim Wahlvolk nicht gut an. Eine Regierung gegen die AfD zu bilden, wird voraussichtlich nur mit Hilfe der unverändert starken Linken gelingen. Die CDU wird hier über ihren Schatten springen müssen - und zeigen, ob auch sie die Zeichen der Zeit verstanden hat.

Pressekontakt:

Frankfurter Rundschau

Ressort Politik

Telefon: 069/2199-3222

Original-Content von: Frankfurter Rundschau, übermittelt durch news aktuell

28.08.2026 – 17:49

Straubinger Tagblatt

Die CSU sollte ein mögliches ÖDP-Volksbegehren nicht unterschätzen

Straubing (ots)

Die Wucht, die ein solches Begehren annehmen kann, sollte die CSU nicht unterschätzen. Bereits in der Vergangenheit hat die ÖDP mehrfach gezeigt, wie sie mit einem vermeintlich chancenlosen Thema Politikgeschichte schreibt: Abschaffung des bayerischen Senats 1998, Rauchverbot 2010 und "Rettet die Bienen" 2019 - allesamt Projekte der ÖDP, die entweder zu Volksentscheiden führten oder die Staatsregierung zum Einlenken brachten.

Und auch inhaltlich hat die ÖDP einen Punkt: Die Konzentration von Macht auf eine Person, die sich daran klammern will, tut in den seltensten Fällen gut. Die Abnutzung und Ermüdung der Wähler nimmt in der Regel zu. Mit einer Amtszeitbegrenzung können sich potenzielle Nachfolger geregelt in Stellung bringen, ohne Gefahr zu laufen, abgewürgt zu werden.

Pressekontakt:

Straubinger Tagblatt

Ressort Politik/Wirtschaft/Vermischtes

Markus Peherstorfer

Telefon: 09421-940 4441

politik@straubinger-tagblatt.de

Original-Content von: Straubinger Tagblatt, übermittelt durch news aktuell

28.08.2026 – 17:55

Brummelt & Müller Immobilien GmbH

Immobilienmarkt Recklinghausen 2026: Ältere Häuser werden für Verkäufer zur Herausforderung: Brummelt & Müller Immobilien über Sanierungsstau, Käufer und realistische Preise

Bild-Infos Download

Recklinghausen (ots)

Der Generationenwechsel dürfte den Immobilienmarkt in Recklinghausen und im Ruhrgebiet in den kommenden Jahren zunehmend prägen. Viele Häuser, die jahrzehntelang von derselben Generation bewohnt wurden, wechseln den Eigentümer. Ein Teil davon wurde zwar kontinuierlich gepflegt, größere Modernisierungen an Heizung, Elektrik, Fenstern oder energetischen Komponenten liegen jedoch teilweise lange zurück. Gleichzeitig beobachten die Immobilienexperten von Brummelt & Müller Immobilien, dass Kaufinteressenten bei stark renovierungsbedürftigen Objekten zurückhaltender reagieren. Für Verkäufer stellt sich deshalb eine entscheidende Frage: Was ist ein älteres Haus tatsächlich wert, wenn Käufer zusätzlich erhebliche Investitionen einkalkulieren?

"Wir nehmen im Moment wirklich vermehrt wahr, dass die Käufer stark renovierungsbedürftige Objekte eher meiden", sagt Marlon Müller von Brummelt & Müller Immobilien. Für Eigentümer wird damit nicht nur der theoretische Immobilienwert entscheidend. Ebenso wichtig ist, wie der Markt den vorhandenen Modernisierungsbedarf bewertet.

Der Generationenwechsel bringt ältere Immobilien auf den Markt

Viele Einfamilienhäuser in Recklinghausen und im Ruhrgebiet befinden sich seit Jahrzehnten im Besitz derselben Familien. Kleinere Reparaturen wurden durchgeführt, Räume renoviert und einzelne Bauteile erneuert. Eine grundlegende Modernisierung ist jedoch nicht bei jeder Immobilie erfolgt.

Solange Eigentümer selbst in ihrem Haus leben, muss das kein Problem darstellen. Anders sieht es aus, wenn die Immobilie im Zuge eines Generationswechsels verkauft werden soll. Dann trifft die persönliche Perspektive der bisherigen Eigentümer auf die wirtschaftliche Kalkulation potenzieller Käufer.

Herr Müller erwartet deshalb, dass ältere Bestandsobjekte den regionalen Markt zunehmend beschäftigen werden. "Die Immobilien, die in den nächsten zehn, zwanzig Jahren auf den Markt kommen, werden renovierungs- oder sanierungsbedürftig sein", lautet seine Einschätzung aus der täglichen Praxis.

Für Verkäufer bedeutet das: Der Zustand einer Immobilie dürfte bei der Preisfindung noch stärker ins Gewicht fallen.

Warum Käufer bei Sanierungsobjekten genauer rechnen

Kaufinteressenten betrachten nicht allein den Angebotspreis. Hinzu kommen Kaufnebenkosten, Finanzierung und mögliche Investitionen nach dem Erwerb. Müssen zusätzlich Heizung, Elektrik, Fenster, Dach oder Innenräume modernisiert werden, verändert das die wirtschaftliche Gesamtbetrachtung erheblich.

Gerade deshalb sind allgemeine Quadratmeterpreise für ältere Immobilien nur eingeschränkt aussagekräftig. Zwei Häuser mit ähnlicher Wohnfläche können aufgrund von Mikrolage, Grundstück, Baujahr, energetischem Zustand und Modernisierungsbedarf sehr unterschiedliche Marktwerte besitzen.

Bei sanierungsbedürftigen Immobilien kommt ein weiterer Faktor hinzu: Nicht jeder Käufer plant dieselben Maßnahmen. Während der eine lediglich Böden und Wände erneuert, möchte ein anderer das Gebäude umfassend modernisieren.

Warum 50.000 Euro Sanierung nicht automatisch 50.000 Euro mehr Verkaufspreis bedeuten

Genau daraus ergibt sich für Eigentümer eine schwierige Entscheidung: Sollte vor dem Verkauf noch investiert werden oder ist es sinnvoller, das Haus im bestehenden Zustand anzubieten?

Eine pauschale Antwort hält Marlon Müller für problematisch.

"Ich kann nicht in die Zukunft schauen. Der eine renoviert aufwändiger, der andere weniger aufwändig."

Ein Käufer verlegt möglicherweise lediglich einen neuen Boden. Ein anderer entfernt vorhandene Beläge bis auf den Estrich, erneuert Elektrik und Heizung und plant zusätzliche energetische Maßnahmen. Die Vorstellungen und damit auch die kalkulierten Kosten können erheblich voneinander abweichen.

Deshalb bedeutet eine Investition von beispielsweise 50.000 Euro vor dem Verkauf nicht automatisch, dass sich anschließend ein um 50.000 Euro höherer Verkaufspreis erzielen lässt.

Gerade in Recklinghausen müssen Investitionen zum regionalen Preisniveau passen. Was sich in besonders hochpreisigen Lagen von Düsseldorf oder Köln wirtschaftlich rechnen kann, lässt sich nicht automatisch auf den Immobilienmarkt im Ruhrgebiet übertragen.

Für Verkäufer ergibt sich daraus eine wichtige Frage: Welche Maßnahmen steigern tatsächlich die Marktchancen und welche Investitionen würde ein späterer Käufer ohnehin nach seinen eigenen Vorstellungen vornehmen?

Vor dem Verkauf nicht automatisch kernsanieren

Ein älteres Haus muss deshalb nicht grundsätzlich vor dem Verkauf umfassend modernisiert werden. Kleinere Maßnahmen können sinnvoll sein, wenn sie den Gesamteindruck verbessern oder offensichtliche Mängel beseitigen. Bei größeren Investitionen sollte dagegen zunächst geprüft werden, ob der Markt diese tatsächlich honoriert.

Denn sanierungsbedürftige Immobilien sind nicht automatisch unverkäuflich. Manche Käufer suchen bewusst ältere Häuser, weil sie Grundriss, Ausstattung und Gestaltung selbst bestimmen möchten. Andere verfügen über handwerkliche Erfahrung und bewerten notwendige Arbeiten anders als Interessenten, die eine sofort bezugsfertige Immobilie suchen.

Entscheidend ist deshalb, Zustand, Käufergruppe und realistischen Verkaufspreis zusammenzubringen.

Brummelt & Müller Immobilien erläutert auf der eigenen Website im Bereich Immobilienbewertung, welche Faktoren bei einer professionellen Wertermittlung berücksichtigt werden.

Bei Sanierungsobjekten entscheidet der realistische Preis

Je größer der Modernisierungsbedarf, desto wichtiger wird die richtige Positionierung am Markt. Ein Wunschpreis lässt sich nicht einfach aus einem theoretischen Immobilienwert und bereits investierten oder geplanten Sanierungskosten ableiten.

Vielmehr müssen Käufergruppe, Zustand, Mikrolage, Finanzierungsmöglichkeiten und Investitionsbedarf gemeinsam betrachtet werden. Gerade bei renovierungsbedürftigen Häusern kann ein zu optimistischer Angebotspreis problematisch sein. Kalkulieren Interessenten bereits erhebliche Modernisierungskosten ein und lässt der Kaufpreis dafür kaum finanziellen Spielraum, verkleinert sich der potentielle Käuferkreis.

Brummelt & Müller setzt deshalb nach eigenen Angaben bei der Immobilienbewertung auf die Verbindung von regionaler Marktkenntnis und einer individuellen Betrachtung des Objekts.

Dabei bringt Marlon Müller zusätzlich einen bautechnischen Hintergrund mit. Er ist gelernter Zimmerer und staatlich geprüfter Techniker für Bautechnik-Hochbau. Gerade bei älteren Bestandsimmobilien ermöglicht diese Erfahrung eine zusätzliche Perspektive auf Zustand und Modernisierungsbedarf.

Der Bestandsmarkt dürfte anspruchsvoller werden

Der Generationenwechsel könnte den Immobilienmarkt in Recklinghausen und im Ruhrgebiet langfristig verändern. Wenn zunehmend Häuser nach mehreren Jahrzehnten den Eigentümer wechseln, dürften auch mehr Immobilien mit Modernisierungsbedarf auf Käufer treffen, die ihre Gesamtinvestition genau kalkulieren.

Für Eigentümer älterer Häuser folgt daraus vor allem eines: Vor dem Verkauf muss nicht automatisch kernsaniert werden. Ebenso wenig sollte bestehender Sanierungsbedarf ignoriert werden.

Entscheidend ist zunächst zu klären, welchen Wert das Haus im aktuellen Zustand besitzt, welche Käufergruppe infrage kommt und welche Investitionen der Markt tatsächlich honoriert.

Damit dürfte beim Hausverkauf in Recklinghausen künftig nicht allein entscheidend sein, wie viel ein Eigentümer noch in sein Haus investieren kann. Mindestens ebenso wichtig wird die Frage, welchen Sanierungsbedarf die nächste Eigentümergeneration bereit ist zu übernehmen.

Weiterführende Informationen finden Sie unter: www.bundm-immobilien.de

Pressekontakt:

Brummelt & Müller Immobilien GmbH

Am Lohtor 4

45657 Recklinghausen

Telefon: 02361 9910929

E-Mail: info@bundm-immobilien.de

Pressekontakt:

ch@keniq.de

Original-Content von: Brummelt & Müller Immobilien GmbH, übermittelt durch news aktuell

Sense Neuro Diagnostics Appoints Scott D. Wampler as Chief Executive Officer

NEWS PROVIDED BY

Sense Neuro Diagnostic

Aug 28, 2026, 13:50 ET

SHARE THIS ARTICLE

Experienced medical device executive to lead the company through its next phase of clinical, regulatory and strategic development

CINCINNATI, Aug. 28, 2026 /PRNewswire/ -- Sense Neuro Diagnostics, a medical technology company developing a novel, non-invasive platform designed to rapidly assess brain injury and neurological emergencies, today announced the appointment of Scott D. Wampler as Chief Executive Officer, effective August 26, 2026.

Wampler brings more than 30 years of experience spanning medical devices, technology development and early-stage companies. Throughout his career, he has supported 61 companies and participated in 38 regulatory submissions, with extensive experience across product development, regulatory strategy, quality systems, intellectual property, capital formation and commercialization.

His appointment comes as Sense Neuro Diagnostics enters an important next phase in the development of its NeuroHawk™ platform. The company is advancing its clinical and regulatory strategy as it works toward its goal of bringing rapid, non-invasive assessment of suspected brain injury closer to the point of care.

"Scott joins Sense at an important point in the company's evolution," said Jack Kraeutler, Co-Chairman of the Board of Directors of Sense Neuro Diagnostics. "We have built a strong foundation around a differentiated technology with the potential to meaningfully change how neurological emergencies are assessed. Scott's depth of experience in medical device development, regulatory strategy and early-stage company leadership is particularly well aligned with the work ahead. The Board is confident in his ability to lead Sense through this next chapter."

Wampler succeeds Gary Kurdziel, who will continue to serve Sense Neuro Diagnostics as a member of its Board of Directors, providing continuity as the company advances its clinical, regulatory and strategic priorities.

"I am honored to join Sense Neuro Diagnostics and lead the company at such an important stage," said Wampler. "Sense has developed a compelling technology platform addressing a significant unmet need in neurological care. I look forward to working with our talented team, Board, clinical collaborators, strategic partners and investors to advance the technology, execute our clinical and regulatory strategy, and ultimately bring this innovation to the patients and healthcare providers who could benefit from it."

Sense Neuro Diagnostics is developing NeuroHawk™, a non-invasive radiofrequency-based technology designed to provide rapid assessment of brain injury without the use of ionizing radiation. The company's long-term vision is to enable neurological assessment earlier in the patient journey, including in emergency departments, emergency medical services, rural and community healthcare settings, and other environments where rapid access to conventional neuroimaging may be limited.

About Sense Neuro Diagnostics

Sense Neuro Diagnostics is a medical technology company developing non-invasive solutions for the rapid assessment and monitoring of neurological conditions. Its NeuroHawk™ platform uses radiofrequency technology and advanced algorithms to evaluate changes within the brain, with the goal of providing clinicians with actionable information earlier in the care pathway.

Sense Neuro Diagnostics is focused on addressing critical unmet needs in stroke, traumatic brain injury and other neurological emergencies where time to assessment can significantly influence clinical decision-making and patient care.

For more information, visit senseneuro.com.

Suzanne Murray: Suzanne@Marca-360.com 

SOURCE Sense Neuro Diagnostic

21%

more press release views with 

Request a Demo

ByHeart Update: FDA Confirms Review of ByHeart's Root Cause Investigation and Action Plan, Following Completion of Facility Inspections

NEWS PROVIDED BY

ByHeart

Aug 28, 2026, 13:52 ET

SHARE THIS ARTICLE

FDA found no factors that could explain the cause of the outbreak in ByHeart facilities

FDA responded with no further questions on ByHeart's investigation and Action Plan

ByHeart introduces new C. botulinum testing protocols 1000x more sensitive than the standard industry test methodology

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- ByHeart today published an update on the company's ongoing response to the November 2025 infant botulism outbreak and its work toward a responsible return to infant formula production.

ByHeart provided the U.S. Food and Drug Administration with an approximately 400-page comprehensive submission detailing the company's root cause investigation findings, assessments conducted by independent food safety experts, complete action plan, new Clostridium botulinum testing protocols, and proposed corrective actions and preventive controls across its supply chain and manufacturing operations. Additionally, FDA and ByHeart agreed on reviewing pending materials on ByHeart's proposed use of a new sporicidal treatment method for facility surfaces and a new whole milk ingredient supplier.

FDA informed ByHeart in writing that outside of the pending items above, it has no further questions regarding the materials submitted.

This represents an important milestone in ByHeart's path forward. It follows FDA's June 3 public update confirming that the agency had completed its on-site inspections of ByHeart's manufacturing facilities. These inspections led to the identification of Clostridium botulinum in a powdered whole milk ingredient sourced from a third-party ingredient supplier. FDA stated that ByHeart facility inspections "did not identify any additional factors within ByHeart's facilities that could explain the cause of this outbreak." The agency also said that its broader root cause investigation remains ongoing, now with a focus on ingredients.

"FDA's review is an important milestone, but it is not the end of our work," said Ron Belldegrun, CEO and Co-Founder of ByHeart. "We are deeply committed to advancing the science of safety, and continuing to share everything we have learned with our community and with the industry. Our published research, as well as presentations at forums like the recent annual meeting of the International Association for Food Protection and C. botulinum-specific industry forums, reflect our commitment to transparency and collaboration to build a safer future for infant formula."

Strengthening Safety From Ingredient to Finished Product

ByHeart's submission brought together the findings of the company's investigation and the work of independent experts. The document highlighted outputs of ByHeart's work with IEH Laboratories, including new research published in Frontiers in Microbiology, and the development of the Advanced C. botulinum Safety Protocol. It also detailed actions which ByHeart has consulted with experts to design in order to strengthen safety throughout the full production system, including:

New testing protocols specifically designed to detect C. botulinum in dairy ingredients and finished infant formula that achieves detection down to 0.01 CFU/g – 1000x more sensitive that the detection limit of SRC direct plating, the standard industry test methodology;

Enhanced supplier qualification, verification and ingredient-testing requirements;

Additional preventive controls across sourcing, manufacturing, sanitation and product release; and

Continued independent scientific and food safety collaboration.

Remaining Steps on the Path to Market

Ahead of restarting infant formula production, ByHeart will provide FDA with 28 days advance notice and complete the required verification activities and pre-production commitments. ByHeart will continue to share additional information as this work advances.

About ByHeart

ByHeart is an infant nutrition company founded with the mission of building a future in which every parent can feel confident about how they feed their baby. The company is committed to advancing infant nutrition through rigorous science, responsible manufacturing and continued collaboration with regulators, researchers and food safety experts.

mediarelations@byheart.com

SOURCE ByHeart

21%

more press release views with 

Request a Demo

LaserAway, Nation's Largest Aesthetic Dermatology Brand, Opens Its 229th Clinic

NEWS PROVIDED BY

LaserAway, LLC.

Aug 28, 2026, 13:53 ET

SHARE THIS ARTICLE

LOCATED AT 5275 UNIVERSITY PKWY #115, UNIVERSITY PARK, FL 34201, this clinic opening marks 20 years of uninterrupted growth for the founder-led, Los Angeles–based company.

LOS ANGELES, Aug. 28, 2026 /PRNewswire/ -- LaserAway, the nation's leader in aesthetic dermatology today announced the opening of its 229th location in University Park, FL. The opening celebrates the company's 20th Anniversary which takes place this year and reflects two decades of continuous growth without a single clinic closure, a rare achievement in retail and the medical aesthetics category.

Founded in 2006 by Dr. Roy Winston and brothers Scott, Brock, and Todd Heckmann, LaserAway has evolved from a single West Hollywood, CA clinic into the largest nationwide aesthetics and dermatology company in the country. All LaserAway locations are privately owned and operated with no franchises. LaserAway's success was built on a simple but disruptive idea: that industry-leading, safe, and effective aesthetic dermatological treatments should be available for everyone.

"When we opened our first clinic on Sunset Boulevard, we knew there was a massive opportunity to make these treatments accessible to everyone—not just a privileged few," said Scott Heckmann, co-founder and CEO of LaserAway. "From day one, our mission has been to combine medical precision with modern convenience, giving people safe, effective results in a setting that feels approachable and empowering."

LaserAway currently operates in 36 states and all treatments are performed by licensed medical professionals (NPs, PAs, RNs). LaserAway's Chief Medical Officer is Dr. Will Kirby. Dr. Kirby leads LaserAway's Medical Board, which consists of a team of over 25 board-certified dermatologists.

The University Park, FL location, like all LaserAway locations, will provide a full range of non- and minimally-invasive aesthetic services, including laser hair removal, Botox®, dermal fillers, skin rejuvenation and body contouring treatments such as CoolSculpting® and Thermage®. It will also feature LaserAway Wellness Injections, administered by medical professionals to support safe, clinically monitored results.

For more information on the brand, please visit laseraway.com.

ABOUT LASERAWAY

LaserAway® is the nation's leader in aesthetic dermatology, offering customized treatments tailored to patient needs with a team of more than 25 board-certified dermatologists and 700 nurses in its 229 locations across the country. It specializes in a full suite of non- and minimally-invasive aesthetic treatments, including laser hair removal, laser tattoo removal, laser skin rejuvenation, body contouring, skin tightening, injectables, and skincare products. LaserAway is committed to providing high-quality, results-driven skincare solutions in a modern and welcoming environment. For more information, visit the brand on Instagram, TikTok, YouTube, LinkedIn, or at www.laseraway.com.

SOURCE LaserAway, LLC.

21%

more press release views with 

Request a Demo